<DOC>
	<DOCNO>NCT03075241</DOCNO>
	<brief_summary>The purpose study determine whether Zolpidem Zoplicone efective treatment sleep disorder Alzheimer 's disease ( AD )</brief_summary>
	<brief_title>Z-Drugs Sleep Disorders Alzheimer 's Disease</brief_title>
	<detailed_description>Sleep disorder ( SD ) affect 35 50 percent patient AD . These disorder often make care patient home difficult . Zolpidem Zoplicone prescribe drug sleep disorder AD patient .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Zolpidem</mesh_term>
	<criteria>55 year age old Diagnosis probable Alzheimer 's disease ( AD ) National Institute Neurological Communicative Disorders Stroke / Alzheimer 's Disease Related Disorders Association Criteria Hachinski Ischemia Scale le 5 MiniMental State Examination score 0 26 Actigraph evidence mean time immobile le 7 hour per night base least 7 night complete actigraph data collect single week Fourweek history sleep disorder behavior , occur least weekly , report caregiver use Neuropsychiatric Inventory ( NPI ) Nighttime Behavior scale Sleep disturbance observe present diagnosis AD Other comorbidities , especially delirium , depression , chronic pain medication use may present , cooperate primary symptom Computed tomography magnetic resonance imaging since onset memory problem show 1 lacunar infract nonstrategic area clinical event suggestive stroke intracranial disease normal Stable medication 4 week prior screen visit Having mobile upper extremity attach actigraph Residing responsible spouse , family member , professional caregiver present night would agree assume role principle caregiver 3week protocol Ability ingest oral medication participate schedule evaluation Sleep disturbance associate acute illness , delirium psychiatric disease Clinically significant movement disorder , akinesia , would affect actigraphic differentiation sleep wakefulness Severe agitation Unstable medical condition Discontinuation psychotropic sleep medication within 2 week screen visit Patient unwilling maintain caffeine abstinence 2:00pm duration protocol Patient unwilling comply maximum limit 2 alcoholic drink per day , 1 alcoholic drink 6:00pm duration protocolo Prior use zolpidem/zoplicone treatment os sleep disturbance Caregiver deem unreliable supervise wear actigraph , administer study capsule proper time , maintain sleep diary , bring patient schedule visit</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Sleep Disturbances</keyword>
	<keyword>Alzheimer Disease</keyword>
	<keyword>Insomnia</keyword>
	<keyword>Z-Drugs</keyword>
	<keyword>Treatment</keyword>
</DOC>